Objectives
Surgeons have multiple grafts options available for the endovascular treatment of abdominal aortic aneurysms (EVAR), and some hypothesize that suprarenal fixation endografts may result in higher rates of renal complications than infrarenal endografts. This study aims to compare the outcomes of contemporary suprarenal and infrarenal endografts.
Methods
The Targeted Vascular Module of the National Surgical Quality Improvement Project was utilized to identify patients undergoing EVAR for infrarenal aneurysm from 2011–2013. Preoperative and operative variables and 30-day outcomes were compared between suprarenal (Zenith and Endurant) and infrarenal fixation devices (Excluder). Renal complications included creatinine increase > 2 mg/dL or new dialysis, as defined by NSQIP. Multivariable regression was completed to account for patient demographics, co-morbidities, and operative characteristics.
Results
3 587 patients were evaluated including 2 273 (63%) with suprarenal grafts and 1 314 (37%) with infrarenal grafts. Patients with suprarenal grafts were less commonly white (84% vs. 88%, P < 0.01) and more commonly male (83% vs. 80%, P = 0.03). There were no differences in age or comorbidities. Renal complications (1.1% vs. 0.1%, P < 0.01) and length of stay >2d (34% vs. 25%, P < 0.01) occurred more commonly after suprarenal fixation. After adjustment, suprarenal grafts had significantly higher rates of renal complications (OR: 12.0, 95% CI: 1.6–91) and length of stay >2d (OR: 1.4, 95% CI: 1.2–1.7).
Conclusion
Overall rates of renal complications following EVAR are quite low. Patients selected for suprarenal stent grafts are at increased risk for renal complications and prolonged length of stay, which may be due to selection bias, deployment techniques, or the presence of a bare stent overlying the renal arteries. Further studies are necessary to evaluate the mechanism and duration of renal dysfunction and important long-term outcomes of interest.